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Reactive oxygen species, endothelial dysfunction,
inflammation, and mitogen-activated protein kinases have
important roles in the pathogenesis of ischemia/reperfusion
kidney injury. Stanniocalcin-1 (STC1) suppresses superoxide
generation in many systems through the induction of
mitochondrial uncoupling proteins and blocks the cytokine-
induced rise in endothelial permeability. Here we tested
whether transgenic overexpression of STC1 protects from
bilateral ischemia/reperfusion kidney injury. This injury in
wild-type mice caused a halving of the creatinine clearance;
severe tubular vacuolization and cast formation; increased
infiltration of macrophages and T cells; higher vascular
permeability; greater production of superoxide and
hydrogen peroxide; and higher ratio of activated extracellular
regulated kinase/activated Jun-N-terminal kinase and p38,
all compared to sham-treated controls. Mice transgenic
for human STC1 expression, however, had resistance to
equivalent ischemia/reperfusion injury indicated as no
significant change from controls in any of these parameters.
Tubular epithelial cells in transgenic mice expressed higher
mitochondrial uncoupling protein 2 and lower superoxide
generation. Pre-treatment of transgenic mice with paraquat,
a generator of reactive oxygen species, before injury restored
the susceptibility to ischemia/reperfusion kidney injury,
suggesting that STC1 protects by an anti-oxidant mechanism.
Thus, STC1 may be a therapeutic target for ischemia/
reperfusion kidney injury.
Kidney International (2012) 82, 867–877; doi:10.1038/ki.2012.223;
published online 13 June 2012
KEYWORDS: free radicals; inflammation; mitochondria; vascular permeability
Ischemic acute kidney injury (AKI) is common and leads to
kidney failure quite often. An acute ischemic insult occurring
immediately after kidney transplantation contributes to ‘early
graft dysfunction’, and may lead to chronic allograft
nephropathy,1,2 while an increase in serum creatinine in
post-surgical patients is associated with poor outcomes.3,4
Moreover, a recent study by Chertow and co-workers5
suggested that a small increase in serum creatinine in patients
admitted to the hospital is associated with increased
mortality, longer hospitalizations, and higher cost of care.
Although we have better understanding of the pathogenesis
of ischemic kidney injury, few therapeutic options are
currently available.
Experimental mouse ischemia/reperfusion (I/R) kidney
injury has been used extensively to study the pathogenesis of
ischemic AKI. Increased generation of reactive oxygen species
(ROS), endothelial dysfunction, vascular congestion at the
corticomedullary junction, and inflammation are critical
players in the pathogenesis of I/R kidney injury.6–10 T cells
and macrophages play important roles in the injury and
repair,11–14 and are believed to home-in on the injured kidney
in response to inflammatory cytokines such as macrophage
chemotactic protein-1 and tumor necrosis factor-1a, pro-
duced locally by cells such as the resident dendritic cells and
injured tubular and endothelial cells.15,16 In addition,
activation of mitogen-activated protein kinases (MAPKs)
occurs immediately after injury,17 and high ratio of active
extracellular regulated kinase (p-ERK) over active Jun-N-
terminal kinase (p-JNK)þ active p38 kinase (p-p38) has been
shown to correlate with protection from I/R kidney injury.18
Studies from our lab show that stanniocalcin-1 (STC1)
suppresses superoxide generation through induction of
mitochondrial uncoupling proteins.19 In cytokine-treated
endothelial monolayer, we have shown that treatment with
STC1 decreases superoxide generation and the activation
of pro-inflammatory signaling pathways, JNK, and nuclear
factor-kB;20 preserves endothelial barrier function;20 and
decreases transendothelial migration of inflammatory cells (T
cells and macrophages).21 On the other hand, treatment of
macrophages with STC1 suppresses superoxide generation22
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and decreases the mobility and response of macrophages to
chemoattractants.23
Mammalian STC1 is ubiquitously expressed.24 It is
secreted as phosphoglycoprotein25,26 and is thought to
function in an autocrine/paracrine manner.27,28 However,
recent reports suggest that mammalian STC1 is also blood-
borne,29,30 attached to a soluble protein,29 and thus may have
additional hormonal functions. STC1 binds to a cell surface
receptor and is targeted to the mitochondria,31 and
subcellular fractionation suggested that more than 90% of
cellular STC1 immunoreactivity is mitochondrial.31 Consis-
tent with these data, we found that addition of recombinant
STC1 protein to the medium of cultured macrophages or
cardiomyocytes is followed by sequestration of the protein in
the mitochondria, upregulation of uncoupling proteins, and
suppression of superoxide generation.19,22 The internaliza-
tion of STC1 into the cell, targeting to and action in the
mitochondria, define STC1 as an intracrine factor.32
On the basis of the above observations, we hypothesized
that STC1 protects from I/R kidney injury through its effects
to decrease the generation of ROS; stabilize endothelial
barrier function; and inhibit inflammation. To test this
hypothesis, we applied a well-established mouse I/R kidney
injury model to wild-type (WT) and STC1 transgene (Tg)
mice that display in the kidney preferential expression of
STC1 Tg in endothelial cells and macrophages,30 and
examined a number of functional, morphological, and
biochemical parameters that correlate with kidney injury
after I/R. Our data suggest that transgenic overexpression of
STC1 confers resistance to I/R kidney injury through
suppression of oxidant stress.
RESULTS
Transgenic overexpression of STC1 confers resistance to I/R
kidney injury: STC1 Tg mice display no change in kidney
function or morphology after I/R
Because of the differences in weight between WT and STC1
Tg mice, we could not rely on changes in serum creatinine for
the assessment of renal function after I/R; hence, to obtain
reliable estimates of glomerular filtration rate, we measured
creatinine clearance (CrCl) and corrected it for the weight.
However, this introduced a caveat. CrCl values for each time
point are based on urine collections that began 20 h earlier;
that is, urine collection for the 24 h time point was started 4 h
after I/R or sham operation, and before the full kidney injury
had occurred. Therefore, the CrCl values for the 24 h time
point do not reflect the full extent of renal injury in WT
kidney, as revealed by the histology 24 h after I/R. Following
I/R and compared to sham-treated controls, WT mice
displayed 50% drop in CrCl at the 48 and 72 h time points
(Figure 1); severe cellular vacuolization, tubular dilatation,
and cast formation that were observed starting 24 h after I/R
and persisted through the 72 h time point (Figure 2b–d). In
contrast, STC1 Tg mice displayed no change in CrCl or
kidney morphology at any time point after I/R. As reported
previously,18 we observed full recovery of kidney function
(Figure 1) and morphology (Figure 2e) in WT mice by day 8.
The data suggest that Tg overexpression of STC1 confers
resistance to I/R kidney injury. Of note, loss of brush border
membrane is characteristic of I/R kidney injury,33,34 and the
absence of such changes in the kidneys of STC1 Tg mice
(Figure 2f–j) is consistent with resistance to I/R injury. Of
interest, STC1 protein expression is induced in WT kidneys
at the 24 h time point following I/R, but not in STC1 Tg
kidneys, and this induction occurs mostly in injured tubule
cells, consistent with STC1 function as cell stress gene.
Staining for STC1 in Tg kidneys remained unchanged, and
was prominent in blood vessels (Figure 3).
Increased infiltration with macrophages and T cells in WT
kidneys following I/R, but not in STC1 Tg kidneys
Inflammation plays an important role in the pathogenesis of I/R
kidney injury, and while the role of neutrophils remains
uncertain,35,36 T cells and macrophages appear to be critical.11,37
Using immunohistochemistry, we examined the kidneys for
infiltration with T cells (CD3) and macrophages (F4/80 and
CD68) following I/R. Compared to sham-treated controls WT
kidneys displayed increased infiltration with T cells (Figure 4a)
and macrophages (F4/80 shown in Figure 4b; staining with
the pan-macrophage marker CD68 showed similar results;
data not shown), starting 24 h after I/R, and persisting through
day 8. In contrast, kidneys of Tg mice displayed no change
in the number of T cells or macrophages after I/R. The
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Figure 1 | Transgenic overexpression of stanniocalcin-1 (STC1)
confers resistance to ischemia/reperfusion (I/R) kidney injury:
STC1 transgenic (Tg) mice display no change in creatinine
clearance (CrCl) after I/R. Mice were killed 24, 48, 72 h, or 8 days
following I/R and blood samples were obtained for creatinine
measurements. Timed urine collections, corresponding to the last
20 h preceding the above time points, were used for creatinine
measurements and CrCl calculations normalized to weight. Bar
graph represents values obtained from at least six mice for each
group at every time point, except for sham bars that represent
cumulative values from all sham-treated mice at all time points
(nX24). WT, wild-type.
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Figure 2 |Transgenic overexpression of stanniocalcin-1 (STC1) confers resistance to ischemia/reperfusion (I/R) kidney injury: STC1
transgenic (Tg) mice display no change in kidney morphology after I/R. Mice were killed 24, 48, 72 h, or 8 days following I/R and kidneys
were subjected to periodic acid–Schiff (PAS) staining. (a) Following I/R and compared to sham-treated controls, (b–d) wild-type (WT) mice
displayed loss of brush border membrane (arrowheads), severe cellular vacuolization (v), and tubular dilatation (dt) with cast formation (c),
starting 24 h after I/R, persisting through the 72 h time point. Glomeruli are marked by the letter ‘g’. (e) Recovery of morphology in WT
kidneys is observed by day 8. In contrast, (f) following I/R and similar to sham-treated controls, (g–j) kidneys of STC1 Tg mice demonstrated
morphological preservation of brush border membrane (arrowheads) throughout the time course, and showed no evidence of cellular
vacuolization, tubular dilatation, or cast formation. Representative images are shown (original magnification  200).
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Figure 3 | Increased expression of stanniocalcin-1 (STC1) protein after ischemia/reperfusion (I/R) in injured tubules of wild-type
(WT) kidneys. (a) Mice were killed 24 h following I/R and proteins representing whole kidney were resolved on sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE); western blots were reacted consecutively with anti-STC1, followed by b-actin, and the ratio
of STC1/b-actin was calculated. Bar graph represents data from six mice for each group and depicts the mean (±s.e.m.). (b) Mice were killed
24 h following I/R and Methacarn-fixed kidneys were subjected to staining with anti-STC1. WT kidneys displayed increased expression of
STC1 in injured tubules (vacuolated cells) following I/R, whereas staining for STC1 in Tg kidneys remained unchanged, and was prominent
on the endothelial surface of arteries (a), interstitial venules (arrowheads), and capillaries in the glomeruli (g). Representative images are
shown (original magnification  200).
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data suggest two possibilities: (1) Tg overexpression of STC1
inhibits inflammation in the kidneys following I/R; alternatively,
(2) the resistance of STC1 Tg mice to I/R kidney injury obviates
the inflammatory response.
Increased activities of MAPKs in the kidneys of WT mice after
I/R, but not in the kidneys of STC1 Tg mice
The activities of MARKs ERK, JNK, and p38 increase
markedly after ischemia in vivo and chemical anoxia
in vitro.38 The relative extent of activation of ERK, JNK, or
p38 has been proposed to determine cell fate after I/R kidney
injury,18,39,40 and the post-ischemic activation patterns of
MAPKs may contribute to the protection afforded by
ischemic pre-conditioning, whereby a higher ratio of p-
ERK/p-p38þ p-JNK promotes cell survival.18
STC1 has been reported to attenuate ERK activity in
mouse embryo fibroblasts,41 and with that in mind, we
sought to determine the activities of MAPKs in the kidneys
24, 48, 72 h, and 8 days following I/R utilizing two
approaches: (1) immunohistochemistry, counting positively
stained cells for p-MAPKs in 10 grids spanning corticome-
dullary junction, where most of MAPK activation following
I/R occurs; (2) similarly, western blot analysis using lysates
representing whole kidney, where p-ERK/ERK was divided by
the sum of p-JNK/JNK and p-p38/p38. We found an increase
in the number of tubular cells positive for p-ERK, p-JNK, and
p-p38 in WT kidneys after I/R; however, we observed no
change in the number of cells stained positive for p-ERK, p-
JNK, or p-p38 in STC1 Tg kidneys (Figure 5). Similarly,
western blot analysis revealed a significant increase in the
activities of all three MAPKs, and a higher ratio of
p-ERK/p-JNKþ p-p38 in WT kidney lysates at the 24 h time
point after I/R, but not in STC1 Tg kidney lysates (Figure 6).
Since activation of MAPKs following I/R is an indication of
acute injury, our data are consistent with lack of injury in
STC1 Tg kidneys after I/R. In addition, one may also
conclude that resistance to I/R kidney injury in STC1 Tg
kidneys occurred in spite of the lower relative ratio of p-ERK/
p-p38þ p-JNK.
Increased vascular permeability after I/R injury in WT
kidneys, but not in STC1 Tg kidneys
Excessive generation of ROS has been implicated in the
pathophysiology of endothelial barrier dysfunction after
I/R.7,8 Disruption of the integrity of this barrier markedly
increases permeability to fluids, macromolecules, and
inflammatory cells.42 In cytokine-treated endothelial mono-
layer, we have shown that STC1 attenuates superoxide
generation,20 maintains the expression of tight junction
proteins,20 stabilizes endothelial barrier function,20 and
diminishes transendothelial migration of T cells and macro-
phages.21 Measuring Evans blue dye retention in the kidney
as a correlate of vascular permeability in vivo, we found
higher Evans blue retention in WT kidneys 5 h after I/R, but
not in STC1 Tg kidneys (Figure 7). The data are consistent
with our hypothesis that STC1 stabilizes endothelial barrier
function in vivo, a mechanism that may contribute to/or
underlie the resistance of STC1 Tg mice to I/R kidney injury.
Increased generation of superoxide and hydrogen peroxide
after I/R in WT kidneys, but not in STC1 Tg kidneys
There is substantial evidence to support a role for ROS in the
pathogenesis of AKI.43 STC1 has been shown by us to
decrease superoxide generation through induction of mito-
chondrial uncoupling proteins.22 In the following experi-
ment, we employed semiquantitative methods to measure
superoxide and hydrogen peroxide (H2O2) in the kidneys of
WT and STC1 Tg mice 24 h after I/R, and found marked
elevation in both superoxide and H2O2 in WT kidneys, but
not in STC1 Tg kidneys (Figure 8). These data are consistent
with our hypothesis that STC1 suppresses the generation of
free radicals, a mechanism that may underlie the resistance of
STC1 Tg mice to I/R.
STC1 protects from I/R kidney injury through suppression of
oxidant stress
STC1 decreases superoxide generation in many cells, includ-
ing endothelial cells and macrophages,20,22 and our current
data show that kidney I/R in STC1 Tg mice does not increase
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Figure 4 |Wild-type (WT) kidneys, but not stanniocalcin-1 (STC1) transgenic (Tg) kidneys, demonstrate increased infiltration with
macrophages and T cells following ischemia/reperfusion (I/R). Mice were killed 24, 48, 72 h, or 8 days following I/R and kidney sections
were stained with anti-CD3 or anti-F4/80. Bar graphs represent cumulative data obtained from at least six mice for each group/time point—
where the mean (±s.e.m.) of CD3 or F4/80 positively stained cells infiltrating 10 grids spanning the inner cortex and corticomedullary
junction (1 cm2 graded ocular grids viewed at original magnification  200) were counted. Following I/R and compared to sham-treated
controls, WT kidneys displayed increased infiltration with (a) T cells (CD3þ ) and (b) macrophages (F4/80þ ). In contrast, kidneys of STC1 Tg
mice displayed no change in the number of T cells or macrophages after I/R. HPF, high-power field.
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superoxide and H2O2. Therefore, we hypothesized that
suppression of free radicals by STC1 may play a critical role
in the protection from I/R kidney injury. Indeed, pre-
treatment of STC1 Tg mice with paraquat (catalyzes the
generation of superoxide) at a low dose, which does not
produce kidney injury by itself (see Figure 9 and Cheng
et al.44) before clamping, recapitulated the results observed in
WT mice after I/R. As shown in Figure 9, administration of
paraquat to STC1 Tg mice before I/R is followed by increased
levels of superoxide (Figure 9a) and H2O2 (Figure 9b) in the
kidneys at the 24–72 h time points post-I/R; drop in CrCl at
the 72 h post-I/R (Figure 9c); and morphological changes in
the kidneys similar to those observed in WT kidneys after I/R
(Figure 9d). On the other hand, pre-treatment of STC1 Tg
mice with saline before I/R did not produce any of these
changes. Consistent with previously published data,44 treat-
ment of STC1 Tg mice with low-dose paraquat alone did not
produce kidney injury (Figure 9c and d). Our data suggest
that suppression of free radicals by STC1 is a primary
mechanism for protection from I/R kidney injury.
Increased expression of UCP2 in tubular epithelium of STC1
Tg kidneys correlates with lower superoxide generation
STC1 Tg mice used for these experiments display high
circulating levels of STC1 protein and preferential expression
of STC1 transgene in endothelial cells of the kidney.30,45 STC1
is a secreted protein and functions in an autocrine/paracrine
manner, and because of the juxtaposition of peritubular
capillaries to epithelial cells, it is expected to act on
neighboring epithelial cells, whether the protein originates
from the circulation or from endothelial cells in the
peritubular capillaries. In macrophages, STC1 suppresses
superoxide generation through induction of UCP2.22 In this
experiment, we sought to determine UCP2 expression in the
kidney using immunohistochemistry, and found higher level
expression of the protein in tubular epithelial cells of STC1
Tg mice at baseline compared with WT mice (Figure 10), and
incubation of kidney slices with MitoSOX reveals lower
baseline levels of superoxide in tubule cells of STC1 Tg
kidneys compared to WT kidneys (Figure 10). The data are
consistent with STC1-induced and UCP2-mediated tubular
cell protection from oxidant stress in STC1 Tg kidneys.
DISCUSSION
While a significant progress has been made in defining the
pathophysiology of ischemic kidney injury, the therapeutic
options for this disease remain limited. Our study demon-
strates resistance of STC1 Tg mice to I/R, as we observe no
significant change in CrCl; tubular morphology; infiltration
with macrophages and T cells; vascular permeability;
production of superoxide and H2O2; and the activities of
MAPKs. How might this resistance be conferred? A recent
study showed dramatic increase in oxidative stress in
critically ill humans with acute kidney failure, as evidenced
by depletion of plasma thiols and increased formation of
carbonyl.46 Animal studies suggest that during ischemia, ATP
is degraded to hypoxanthine, and after restoration of oxygen
supply to the ischemic kidney, hypoxanthine is converted to
xanthine by xanthine oxidase—generating superoxide and
H2O2 in the process.
47 In the presence of iron, H2O2 forms
hydroxyl radicals, which are highly reactive.48 ROS cause cell
injury by oxidation of proteins, peroxidation of lipids, and
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Figure 5 | Increased number of cells with active mitogen-
activated protein kinases (MAPKs) in the kidneys of wild-type
(WT) mice after ischemia/reperfusion (I/R), but not in the
kidneys of stanniocalcin-1 (STC1) transgenic (Tg) mice. Mice
were killed 24, 48, 72 h, or 8 days following I/R and kidney sections
were stained with anti-p-ERK, anti-p-JNK, or anti-p-p38 kinase. Bar
graphs represent cumulative data obtained from at least six mice
for each group/time point—where the mean (±s.e.m.) of p-ERK,
p-JNK, or p-p38 kinase positively stained cells in 10 grids (1 cm2
graded ocular grids viewed at original magnification  200)
spanning the inner cortex and corticomedullary junction were
counted. Following I/R and compared to sham-treated controls,
WT kidneys displayed increased number of cells positively stained
for active MAPKs. In contrast, kidneys of STC1 Tg mice displayed
no change in the number of cells positively stained for active
MAPKs. ERK, extracellular regulated kinase; JNK, Jun-N-terminal
kinase.
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DNA damage, eventually causing cell death.49,50 Indeed,
administration of the superoxide scavenger, superoxide
dismutase, before renal artery clamping and again before
release of the clamp protects from I/R kidney injury.50 These
findings strongly suggest a primary role for free radicals in
the pathogenesis of ischemic AKI. Similarly, our findings
suggest that inhibition of free radicals by STC1 is critical for
the resistance displayed by STC1 Tg mice to I/R kidney
injury, as administration of paraquat (a superoxide gen-
erator) to STC1 Tg mice before clamping of the renal pedicles
recapitulates the results observed in WT kidneys after renal
pedicles clamping.
I/R kidney injury results from a dynamic and complex
interaction between the vasculature and the tubules, whereby
vascular events alter oxygen and nutrient delivery to the
epithelial cells, while the injured epithelium responds by
producing autocrine/paracrine factors and cytokines that
affect the survival of epithelial cells, and impact kidney
function.51 Recent observations by Brodsky et al.9 strongly
suggest that endothelial cell dysfunction is the primary cause
of cortical peritubular capillary no-flow phenomenon that
follows I/R, and prevention of endothelial insult protects
from AKI. In cytokine-treated endothelial cells, we have
previously shown that STC1 blocks superoxide generation;20
preserves endothelial barrier function;20 and decreases
transendothelial migration of leukocytes.21 On the other
hand, treatment of macrophages with STC1 diminishes the
response to chemoattractants23 and suppresses superoxide
generation through induction of mitochondrial UCP2.22 It is
worth noting again that kidneys of STC1 Tg mice used in our
experiments display preferential expression of STC1 trans-
gene in endothelial cells and macrophages,30 and our data
reveal no change in vascular permeability in the kidneys of
STC1 Tg mice after I/R injury, suggesting that STC1 protects
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Figure 6 |Higher p-ERK/p-p38þp-JNK in wild-type (WT)
kidneys after ischemia/reperfusion (I/R) compared with
stanniocalcin-1 (STC1) transgenic (Tg) kidneys. Mice were
killed 24, 48, 72 h, or 8 days following I/R and proteins
representing whole kidney lysates were resolved on sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE);
western blots were reacted consecutively with anti-MAPK,
followed by the respective anti-p-MAPK, and the ratio of p-MAPK/
total MAPK was calculated. Bar graph represents data from 5–7
mice for each group/time point and depicts the mean (±s.e.m.) of
p-ERK/total ERK divided by the sum of p-JNK/total JNKþp-p38/
total p38. Data show higher p-ERK/p-JNKþp-p38 in WT kidney
lysates at the 24 h time point compared to STC1 Tg kidney lysates.
ERK, extracellular regulated kinase; JNK, Jun-N-terminal kinase.
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Figure 7 | Increased vascular permeability after ischemia/
reperfusion (I/R) injury in wild-type (WT) kidneys, but not in
stanniocalcin-1 (STC1) transgenic (Tg) kidneys. At 5 h after I/R,
mice were given an injection of 2% Evans blue dye through the
tail vein. Mice were anesthetized 5min after dye injection, and
kidneys were perfused continuously with phosphate-buffered
saline (PBS) for 20min. Kidneys were then homogenized and dye
retention was measured fluorometrically. Bar graphs represent the
mean (±s.e.m.) of data obtained from nine mice for each group
and show higher Evans blue retention in WT kidneys after I/R, but
not in STC1 Tg kidneys. o.d., optical density.
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Figure 8 | Increased generation of superoxide and hydrogen peroxide (H2O2) after ischemia/reperfusion (I/R) in wild-type (WT)
kidneys, but not in stanniocalcin-1 (STC1) transgenic (Tg) kidneys. Mice were killed 24 h following I/R and kidneys were analyzed for
superoxide and H2O2 using semiquantitative methods. Bar graphs represent the means (±s.e.m.) of data obtained from at least six mice
from each group, and show marked elevation of both superoxide and H2O2 in WT kidneys after I/R, but not in STC1 Tg kidneys.
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endothelial cells in vivo as well. Is overexpression of STC1 in
endothelial cells sufficient for renal protection from I/R? The
answer to this question may not be easy to determine,
because STC1 is a secreted protein and functions in an
autocrine/paracrine manner; hence, limiting the effect of
STC1 to a single cell type will be difficult. STC1 produced by
endothelial cells is expected to act on neighboring cells, and
because of the juxtaposition of epithelial cells to peritubular
capillaries, it is highly likely that epithelial cells are exposed to
STC1, whether the protein originates from endothelial cells
in the peritubular capillaries or the circulation, where high
levels of STC1 exist in this Tg mouse line. Because STC1
induces uncoupling proteins,19,22 we examined the expres-
sion of UCP2, the prevailing uncoupling protein in the
kidney, and found higher level expression of UCP2 in tubular
epithelial cells of STC1 Tg kidneys, and as expected,
incubation of kidney slices with MitoSOX reveals lower
baseline levels of superoxide in tubule cells of STC1 Tg
kidneys compared with WT kidneys, consistent with a
mechanism of action for STC1-induced and UCP2-mediated
suppression of superoxide generation in epithelial cells.
It was traditionally thought that uncoupling of the
mitochondria increases the generation of ROS. The evidence
suggests otherwise. A group of UCP1 homologues has been
discovered recently (UCP2 in the lymphoid system and
kidney; UCP3 in the heart and skeletal muscle; UCP4 and
UCP5 in the brain52–54), and like pharmacological uncou-
plers,55 they diminish superoxide generation.52,53,56 Consis-
tent with these observations, increased expression of UCP2 in
tubular epithelial cells suppresses the generation of ROS.
Therefore, it is likely that the resistance to I/R kidney injury
displayed by STC1 Tg mice is mediated through action of
STC1 to protect the epithelium from oxidant injury, and
preserve endothelial barrier function; but in addition, we
cannot dismiss possible contribution of STC1 action to
inhibit macrophages. However, irrespective of how STC1
works, our data identify STC1 as an inducer of anti-oxidant
pathway(s) relevant to the pathogenesis of I/R kidney injury,
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Figure 9 | Stanniocalcin-1 (STC1) protects from ischemia/reperfusion (I/R) kidney injury through suppression of oxidant stress. STC1
transgenic (Tg) mice were given a single intraperitoneal injection of saline or paraquat (12.5mg/kg) 2 h before clamping, and killed 24 h, or
72 h following I/R. (a) Superoxide, (b) hydrogen peroxide (H2O2), (c) creatinine clearance (CrCl) expressed as % of saline-treated sham
controls, and (d) periodic acid–Schiff (PAS) staining for morphology were carried out as detailed in methods. Bar graphs (a, b and c)
represent data from at least six mice for each group/time point, and depict the mean values (±s.e.m.). Representative PAS-stained images
are shown in d. In paraquat-pre-treated STC1 Tg mice, I/R results in increased superoxide and H2O2 levels at the 24–72 h time points post-I/R;
drop in CrCl at the 72 h post-I/R; and morphological changes similar to those observed in WT mice after I/R. Representative images are
shown (original magnification  200).
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and suggest that STC1 may be an important therapeutic
target for the management of ischemic injury in the kidney
and other organs.
To illustrate the efficacy of a particular maneuver in the
setting of I/R, studies usually focus on a single experimental
variable under conditions where the severity of injury is
optimal; this approach has demonstrated limited yield thus
far. To complicate things further, protective actions attributed
to parenchymal cells may be mediated through effects on the
epithelium, the endothelium, or both, and demonstration of
effects on proximal tubules does not necessarily mean they
are limited to this site. For example; treatment of rats with
Tin induces heme oxygenase and protects from I/R kidney
injury, and while the expression of heme oxygenase is highest
in cortical proximal tubules, global tubule cell protection in
the outer medulla is observed,57 suggesting that endothelial
expression of heme oxygenase or other factors may
contribute to the protection in this setting.58 Thus, successful
treatment of ischemic AKI requires taking into account the
complexity of this process, and requires the deployment of
multi-pronged approaches—targeting key cells or processes
that play important roles in the pathogenesis of I/R, as is the
case with STC1 protein.
MATERIALS AND METHODS
Materials
All materials were purchased from Sigma (St Louis, MO), unless
stated otherwise. MitoSOX was purchased from Invitrogen (Carls-
bad, CA). Creatinine measurement kit was purchased from Abcam
(Cambridge, MA). Goat anti-UCP2 was purchased from Lifespan
Biosciences (Seattle, WA). Goat anti-hSTC1 antibodies were
purchased from Santa Cruz (Santa Cruz, CA); rabbit anti-STC1
antibodies were a gift from Dr Gert Flik.59 Rabbit anti-ERK, rabbit
anti-p-ERK, rabbit anti-JNK, rabbit anti-p-JNK, rabbit anti-p38
kinase, and rabbit anti-p-p38 kinase were purchased from Cell
Signaling (Danvers, MA). Rabbit anti-actin was purchased from
Sigma; rat anti-F4/80, rat anti-mouse CD3, and rat anti-CD68 were
purchased from AbD Serotec (Raleigh, NC). Fluorescein isothio-
cyanate-labeled anti-goat antibody was purchased from Invitrogen
(Carlsbad, CA).
Mice
STC1 Tg mice were generated by Varghese et al.,45 and made
available for our studies. STC1 Tg is driven by the metallothionein I
minimal promoter over C57B/6 genetic background.45 Transgenic
mice are 30–40% smaller in size relative to WT litter mates,45 and
display elevated serum STC1 and normal serum calcium.45 Blood
pressure is normal,30 as well as hematocrit (50% WT, 52% STC1 Tg;
P¼NS) and baseline serum creatinine (0.10±0.004 mg/dl WT,
0.11±0.016 mg/dl STC1 Tg; P¼NS). Of note, STC1 expression in
the kidneys of STC1 Tg mice is similar to that of WT mice, except
for higher expression in endothelial cells and macrophages.30 All
studies were carried out using mice homozygous for the transgene
(derived from line 2; Varghese et al.45) and WT mice generated from
crosses between mice heterozygous for the transgene. Mice were
maintained in air-conditioned rooms under pathogen-free condi-
tions with 12h/12 h light/dark cycles, and were given free access to
food and water during the experiments. The investigation conforms
to the Guide for the Care and Use of Laboratory Animals published
by the US National Institutes of Health (NIH Publication No. 85-23,
revised 1996), and animal experiments were approved by university
ethics review board.
AKI model
We used an established mouse model of kidney I/R injury induced
by clamping of bilateral renal pedicles.60 Briefly, male and female
mice (12–20 weeks, 22–25 g) were anesthetized with an intraper-
itoneal injection of 2 ml/kg of combination anesthetic (contains per
1 ml: ketamine 37.5 mg, xylazine 1.9 mg, and acepromazine
0.37 mg). Following abdominal incision, left and right renal pedicles
were bluntly dissected and a non-traumatic vascular clamp (Roboz
Surgical Instruments, Gaithersburg, MD) was placed on each renal
pedicle for 30 min. During the procedure, animals were kept under
heating lamp and hydrated with warm saline. After 30 min of
ischemia, the clamps were removed, the wounds sutured, and the
animals were allowed to recover. Sham-treated animals underwent
similar surgical procedures without clamping of the renal pedicles.
For some experiments, a portion of STC1 Tg mice were given a
single intraperitoneal injection of saline or paraquat at 12.5 mg/kg,
2 h before clamping/sham surgery. Mice were killed at 24, 48, 72 h,
WT
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Figure 10 | Increased expression of UCP2 in tubular
epithelium of stanniocalcin-1 (STC1) transgenic (Tg) kidneys
correlates with decreased superoxide generation. Upper
panels: Methacarn-fixed kidney sections from wild-type (WT) and
STC1 Tg mice where stained with anti-UCP2, followed by
fluorescein isothiocyanate (FITC)-labeled secondary antibodies.
Representative images are shown (original magnification  20)
and demonstrate higher level expression of UCP2 in tubular
epithelial cells of STC1 Tg kidneys. Lower panels: freshly isolated
kidney slices were incubated with MitoSOX for 10min, fixed in 4%
paraformaldehyde, and paraffin embedded; 5 mm sections were
viewed under fluorescence microscope. Representative images
are shown (original magnification  200), and demonstrate lower
level MitoSOX red fluorescence (superoxide) in tubular epithelial
cells of STC1 Tg kidneys, corresponding to higher levels of UCP2
expression.
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or 8 days after surgical procedure; blood samples were obtained via
cardiac puncture (for creatinine measurement); and kidneys were
harvested for the analysis of histology, immunohistochemistry,
western blotting to assess the activities of MAPKs and STC1 protein
expression, and superoxide and H2O2. Before being killed, a timed
urine collection was obtained for the calculation of CrCl. Because of
the sexual dimorphism in the susceptibility to I/R kidney injury,61–63
we included both genders in our studies—to determine the impact
of STC1 on the post-I/R phenotype in male and female mice.
Assessment of renal function
For timed urine collection, mice were placed in metabolic cages for
20 h before being killed. Serum creatinine was measured using
capillary electrophoresis method (courtesy of the Physiology Core
lab, O’Brien Kidney Center, University of Texas Southwestern
Medical Center, Dallas, TX). Urine creatinine was measured using
Abcam creatinine assay kit, as per the manufacturer’s instructions,
and the results were verified by parallel measurements of random
samples using the hospital clinical lab. CrCl was calculated and
normalized to weight.
Vascular permeability
At 5 h after I/R (optimal, based on time course), mice were given 2%
Evans blue dye (0.5 mg/25 ml/g weight) in phosphate-buffered saline
(PBS; composition: 3.2 mmol/l Na2HPO4; 0.5 mmol/l KH2PO4;
1.3 mmol/l KCl; 135 mmol/l NaCl; pH 7.4), delivered through the
tail vein. At 5 min after dye injection, mice were anesthetized and
perfused with PBS continuously for 20 min through cardiac
puncture. Kidneys were removed, weighed, and suspended in cold
PBS (1 g tissue/3 ml buffer), homogenized using MAX Digital High
Viscosity Mixer (Henry Troemner LLC, Thorofare, NJ) and Kontes
Glass Duall tissue grinder (size 21; Fisher Scientific, Pittsburgh, PA),
and centrifuged for 20 min at 4 1C 10,000 r.p.m., on bench top
centrifuge. The supernatant was recovered and the pellet was washed
in PBS and centrifuged again as above, followed by recovery of the
second supernatant. Pooled supernatants were treated with deoxy-
cholic acid (1% final) to decrease turbidity secondary to lipids
(opaque supernatant), and absorbance was measured at 540 nm
(represents retention of Evans blue in the kidney, and corresponds
to vascular permeability).
Immunohistochemistry
Frozen or Methanol-Carnoy (Methacarn)–fixed kidney sections
(4mm) were subjected to: periodic acid Schiff staining (for
morphology); anti-F4/80; anti-CD68 (pan-macrophage marker);
anti-CD3 (lymphocytes); anti-p-p38 (active kinase); anti-p-ERK
(active kinase); anti-p-JNK (active kinase); anti-STC1; or anti-
UCP2. Detection was carried out using peroxidase enzyme–based
detection system (Vector Laboratories, Burlingame, CA) or
fluorescein isothiocyanate–labeled secondary antibody for UCP2.
Photomicrographs were taken using Nikon Eclipse 80i microscope
system. Total macrophages (CD68þ ), resident macrophages/den-
dritic cells (F4/80þ ), and T cells (CD3þ ) infiltrating the
interstitium in an area spanning the inner cortex and corticome-
dullary junction were counted, and the results were expressed as the
means and standard error of means (±s.e.m.) of positively stained
cells in 10 grids (1 cm2 graded ocular grids viewed at original
magnification  200). In situ activity of MAPKs, tubular or
interstitial cells positively stained for active kinases p-ERK, p-JNK,
or p-p38 kinase, were counted as above.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
Lysates representing whole kidney from WT or STC1 Tg mice45 were
suspended in modified radioimmunoprecipitation assay buffer
(composition: 150 mmol/l NaCl; 50 mmol/l Tris-HCl (pH 7.4); 1%
NP-40; 0.25% sodium deoxycholate; 1 mmol/l ethylenediaminete-
traacetic acid; 1 cocktail proteinase inhibitors), and centrifuged
at 8000 g for 10 min, 4 1C, to remove cell debris. In all, 50mg
representing whole kidney protein were resolved on 12% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis, transferred to
nitrocellulose membrane, and incubated with primary antibodies
for: STC1, ERK; p-ERK; JNK; p-JNK; and p38 kinase or p-p38
kinase. After washing with PBS containing 0.1% Tween-20, the
membrane was incubated with horse radish peroxidase–conjugated
secondary antibody. The bound antibodies were visualized using
chemiluminescence.
Superoxide measurements
At 24 h after I/R, kidneys were harvested and homogenized (as
above) in 500 ml sucrose buffer (composition: 0.31 mol/l sucrose;
10 mmol/l Tris-HCl; pH 7.4) on ice, followed by protein quantita-
tion (Bradford’s method). Kidney lysates (100 mg protein/100ml)
were placed in clear flat-bottom wells (96-well plate), containing
excess dihydroethidium (100 mmol/l), in a final volume of 100 ml.
The absorbance (excitation at 530 nm and emission at 620 nm) was
immediately measured. Absorbance values were normalized to the
absorbance of wells containing equimolar concentrations of
dihydroethidium alone, and expressed as o.d. (optical density)/mg
protein.
H2O2 measurements
At 24 h after I/R, kidneys were harvested and homogenized (as
above) in 500 ml sucrose buffer on ice, followed by protein
quantitation (Bradford’s method). H2O2 was measured as described
by Jiang et al.64 The method takes advantage of the conversion of
Fe2þ to Fe3þ in the presence of H2O2, followed by detection of
Fe3þ–xylenol orange complex. Briefly, kidney lysate (100 mg/20ml)
was added to 180 ml assay buffer (composition: 100mmol/l xylenol
orange; 250 mmol/l ammonium ferrous sulfate; 4 mmol/l butylated
hydroxytoluene; 25 mmol/l H2SO4; in methanol), incubated at room
temperature for 30 min, followed by measurement of absorbance at
560 nm. Absorbance values were normalized to the absorbance of
wells containing assay buffer alone, and expressed as o.d./mg
protein.
MitoSOX fluorescence
Freshly isolated kidneys were sectioned coronally to obtain 1-mm-
thick slices that were incubated in PBS containing 5 mmol/l
MitoSOX Red reagent for 10 min. MitoSOX permeates live cells
and selectively targets the mitochondria. It is rapidly oxidized by
superoxide and emits red fluorescence. Following incubation with
MitoSOX, kidney slices were rinsed in PBS, fixed in 4%
paraformaldehyde, embedded in paraffin, and 5 mm sections were
viewed under fluorescence microscope.
MAPKs activities in whole kidney
Whole kidney lysates were resolved on 12% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis and western blots were reacted
with MAPK antibodies, followed by stripping and reaction with
phospho-MAPK antibodies. Bands representing phospho-MAPKs
were normalized to the corresponding bands representing total
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MAPKs (p-ERK/ERK; p-JNK/JNK; p-p38/p38), and expressed as
means±s.e.m. of 3–5 independent determinations.
Statistics
Data are expressed as means±s.e.m. and are compared by one-way
analysis of variance for three or more groups, or unpaired t-test.
Statistical significance of difference was defined by a P-value of
o0.05.
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